Tell ViiV: Expand access to lifesaving HIV treatment

Doctors Without Borders/Médecins Sans Frontières (MSF) is committed to providing comprehensive care to our patients living with, or at high risk of contracting, HIV—from HIV testing with pre- and post-testing counseling to prevention, treatment, and so much more. 

A lifesaving drug manufactured by the pharmaceutical company ViiV is currently the most effective form of long-acting pre-exposure prophylaxis (PrEP) for people at high risk of contracting HIV. However, the company has not done enough to ensure our patients can access this game-changing medication.

Add your name to join our call for ViiV to increase transparency and access to this lifesaving HIV treatment.

Doctors Without Borders/Médecins Sans Frontières (MSF) is committed to providing comprehensive care to our patients living with, or at high risk of contracting, HIV—from HIV testing with pre- and post-testing counseling to prevention, treatment, and so much more. 

A lifesaving drug manufactured by the pharmaceutical company ViiV is currently the most effective form of long-acting pre-exposure prophylaxis (PrEP) for people at high risk of contracting HIV. However, the company has not done enough to ensure our patients can access this game-changing medication.

Add your name to join our call for ViiV to increase transparency and access to this lifesaving HIV treatment.

By submitting this form to MSF-USA, you’ll receive regular updates on our work in the field through emails and SMS messages (if mobile number is provided). You can update your preferences or unsubscribe at any time.